DE69925491D1 - Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen - Google Patents

Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen

Info

Publication number
DE69925491D1
DE69925491D1 DE69925491T DE69925491T DE69925491D1 DE 69925491 D1 DE69925491 D1 DE 69925491D1 DE 69925491 T DE69925491 T DE 69925491T DE 69925491 T DE69925491 T DE 69925491T DE 69925491 D1 DE69925491 D1 DE 69925491D1
Authority
DE
Germany
Prior art keywords
treatment
beclomethasone dipropionate
inflammable
endurance
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925491T
Other languages
English (en)
Other versions
DE69925491T2 (de
Inventor
Paolo Chiesi
Rossella Musa
Eva Bernini
Nicola Castiglione
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Original Assignee
Chiesi Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA filed Critical Chiesi Farmaceutici SpA
Application granted granted Critical
Publication of DE69925491D1 publication Critical patent/DE69925491D1/de
Publication of DE69925491T2 publication Critical patent/DE69925491T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
DE69925491T 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen Expired - Lifetime DE69925491T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI981741 1998-07-28
IT1998MI001741A IT1301947B1 (it) 1998-07-28 1998-07-28 Formulazioni farmaceutiche di beclometasone dipropionato per iltrattamento di malattie infiammatorie croniche della mucosa
PCT/EP1999/005160 WO2000006132A2 (en) 1998-07-28 1999-07-20 Pharmaceutical formulations comprising beclomethasone dipropionate for the treatment of inflammatory bowel disease

Publications (2)

Publication Number Publication Date
DE69925491D1 true DE69925491D1 (de) 2005-06-30
DE69925491T2 DE69925491T2 (de) 2006-02-02

Family

ID=11380533

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69925491T Expired - Lifetime DE69925491T2 (de) 1998-07-28 1999-07-20 Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen
DE69938939T Expired - Lifetime DE69938939D1 (de) 1998-07-28 1999-07-20 Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69938939T Expired - Lifetime DE69938939D1 (de) 1998-07-28 1999-07-20 Pharmazeutische Zusammensetzung enthaltend Beclomethason-Dipropional zur Behandlung entzündlicher Darmerkrankungen

Country Status (9)

Country Link
EP (2) EP1100481B1 (de)
AT (2) ATE296092T1 (de)
AU (1) AU5411999A (de)
DE (2) DE69925491T2 (de)
DK (1) DK1100481T3 (de)
ES (1) ES2243068T3 (de)
IT (1) IT1301947B1 (de)
PT (1) PT1100481E (de)
WO (1) WO2000006132A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263582B2 (en) * 2001-03-15 2012-09-11 Soligenix, Inc. Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
WO2004026257A2 (en) * 2002-09-20 2004-04-01 The Board Of Regents Of The University Of Texas System Treatment of irritable bowel syndrome and related bowel diseases
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4350690A (en) * 1980-10-27 1982-09-21 Cressington Investments Ltd. Steroid composition
IT1222414B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Composizioni farmaceutiche contenenti trapidil,loro procedimento di preparazione e relaticvo impiego terapeutico
IL92343A0 (en) * 1988-12-20 1990-07-26 Gist Brocades Nv Granulate for multiparticulate controlled release oral compositions,their preparation and oral pharmaceutical compositions containing them
AU1587392A (en) * 1991-03-15 1992-10-21 Norwich Eaton Pharmaceuticals, Inc. The use of 5-aminosalicylic acid in the treatment of irritable bowel syndrome - diarrheal phase or type (ibs-d)
US5352681A (en) * 1991-06-07 1994-10-04 Byk Nederland Bv Pharmaceutical enema preparation
GB9414699D0 (en) * 1994-07-21 1994-09-07 Slagel David Aqueous foamable composition
EP0876142B1 (de) * 1996-01-16 2001-09-26 Advanced Polymer Systems, Inc. Örtliche arzneistoffabgabe in tieferen magendarmtraktabschnitten
ATE269710T1 (de) * 1997-09-26 2004-07-15 Medeva Europ Ltd Pharmazeutische zusammensetzung für die behandlung von enzündlichen darmerkrankungen

Also Published As

Publication number Publication date
DE69925491T2 (de) 2006-02-02
DK1100481T3 (da) 2005-09-05
EP1486209B1 (de) 2008-06-18
EP1486209A3 (de) 2004-12-22
ES2243068T3 (es) 2005-11-16
EP1486209A2 (de) 2004-12-15
WO2000006132A3 (en) 2000-04-27
WO2000006132A2 (en) 2000-02-10
ATE296092T1 (de) 2005-06-15
PT1100481E (pt) 2005-09-30
DE69938939D1 (de) 2008-07-31
ITMI981741A0 (it) 1998-07-28
EP1100481A2 (de) 2001-05-23
IT1301947B1 (it) 2000-07-20
ATE398454T1 (de) 2008-07-15
AU5411999A (en) 2000-02-21
EP1100481B1 (de) 2005-05-25
ITMI981741A1 (it) 2000-01-28

Similar Documents

Publication Publication Date Title
EA200001125A1 (ru) Гелеобразные фармацевтические композиции
ATE396967T1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
TR200102817T2 (tr) Antiinflamatuar ajanlar olarak faydalı bileşikler
AR024233A1 (es) Compuestos moduladores de ccr5, composiciones farmaceuticas, su uso en medicina.
FR2714830B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
IS6557A (is) Blandaðar sjúkdómsmeðferðir úr blóðþrýstingslækkandi efnum og efnum sem hamla æðamyndun
ATE489379T1 (de) 2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
TR200100894T2 (tr) Aril ikameli propanolamin türevleri, imalat yöntemleri, ilaç maddeleri, kullanımları.
HRP20060251A2 (en) Substituted oxasolidinones and their use
IL173684A0 (en) Disodium-4,4'-azo-bis-salicylate and pharmaceutical compositions containing the same
HK1113971A1 (en) Oral formulations for delivery of catecholic butanes including ndga compounds
ATE431149T1 (de) Analoge der barbitursäure als therapeutische wirkstoffe
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
DE60334773D1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
DE60213404D1 (de) Verwendung von sulodexid zur behandlung von reizdarm
EA200301022A1 (ru) Гормональная заместительная терапия
BR0008509A (pt) Composição farmacêutica oral estabilizada contendo iodeto e iodato e método
SE9801495D0 (sv) Protein formulationa
ATE191719T1 (de) Analoge des calcitonin aus lachs, ihre herstellung und ihre verwendung als medizin und als analytische reagentien
DE69940633D1 (de) Medizinische Zusammensetzungen enthaltend 2-Amino-2-Ä2-(4-octylphenyl)ethylÜpropan-1,3-diol
ATE215817T1 (de) Feste miltefosin enthaltende arzneimittel zur oralen verabreichung bei der behandlung von leishmaniasis
Huang et al. Induction of cyclooxygenase-2 mRNA and protein expression by epoxy resin and zinc oxide-eugenol based root canal sealers in human osteoblastic cells
DE69925491D1 (de) Pharmazeutische zusammensetzung enthaltend beclomethason-dipropionat zur behandlung entzündlicher darmerkrankungen
TNSN01076A1 (fr) Associations de secretagogues d'hormone de croissance et d'antidepresseurs, et compositions les contenant
DK0917460T3 (da) Cyclosporin-formulering

Legal Events

Date Code Title Description
8364 No opposition during term of opposition